Drk Krankenhaus Chemnitz-Rabenstein

Chemnitz 09117

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) — Running, not enrolling